Original Research

Published on 23 Jan 2023

Non-enhanced magnetic resonance imaging-based radiomics model for the differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qi Li
Xuezhou Li
Wenbin Liu
Jieyu Yu
Yukun Chen
Mengmeng Zhu
Na Li
Fang Liu
Tiegong Wang
Xu Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1108545

1,179 views
1 citation

Original Research

Published on 20 Jan 2023

Age independent survival benefit for patients with small hepatocellular carcinoma undergoing percutaneous cryoablation: A propensity scores matching study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huixin Zhang
Muoyan Xu
Jiashen Shao
Huifang Kong
Xudong Gao
Wei Zhang
Xiujuan Chang
Bin Yang
Yan Chen
Zheng Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1072054

1,426 views

Original Research

Published on 19 Jan 2023

Developing and validating a nomogram based on skeletal muscle index and clinical scoring system for prediction of liver failure after hepatectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Cong Ding
Jianye Jia
Lei Han
Wei Zhou
Ziyan Liu
Genji Bai
Qian Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1036921

922 views

Original Research

Published on 19 Jan 2023

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zi-Han Zhang
Si-Nan Hou
Jia-Ze Yu
Wen Zhang
Jing-Qin Ma
Min-Jie Yang
Qing-Xin Liu
Ling-Xiao Liu
Jian-Jun Luo
Xu-Dong Qu

Frontiers in Oncology

doi 10.3389/fonc.2022.1086095

2,142 views
8 citations

Review

Published on 16 Jan 2023

Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xuenan Peng
Caifeng Gong
Wen Zhang
Aiping Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1091088

3,872 views
3 citations

Original Research

Published on 13 Jan 2023

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xia Zhang
Lirong Cai
Jian Fang
Fengsui Chen
Fan Pan
Kun Zhang
Qian Huang
Yuju Huang
Dongliang Li
Lizhi Lv

Frontiers in Oncology

doi 10.3389/fonc.2022.1101351

1,508 views
3 citations

Review

Published on 13 Jan 2023

Long-term effect of anesthesia choice on patients with hepatocellular carcinoma undergoing open liver resection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Runzhi Zhao
Xiyuan Xu
Li Sun
Guohua Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.960299

2,937 views
6 citations

Original Research

Published on 13 Jan 2023

A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hao Wang
Ruo-Fei Tian
Xue Liang
Jing Fan
Zi-Chuan Duan
Xin-Yu Fan
Jia-Jia Zhang
Dong-Sheng Yao
Zhi-Nan Chen
Ling Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1015042

4,334 views
6 citations

Original Research

Published on 12 Jan 2023

Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hem D Shukla
Tijana Dukic
Sanjit Roy
Binny Bhandary
Andrew Gerry
Yannick Poirier
Narottam Lamichhane
Jason Molitoris
France Carrier
Aditi Banerjee

Frontiers in Oncology

doi 10.3389/fonc.2022.1072774

3,088 views
5 citations

Review

Published on 11 Jan 2023

The evolving role of radiation in pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Midhun Malla
Fatemeh Fekrmandi
Nadia Malik
Hassan Hatoum
Sagila George
Richard M. Goldberg
Sarbajit Mukherjee

Frontiers in Oncology

doi 10.3389/fonc.2022.1060885

9,106 views
7 citations

Original Research

Published on 09 Jan 2023

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhongyuan Cui
Jielong Wang
Gang Chen
Dongliang Li
Bianqiao Cheng
Yanhua Lai
Zhixian Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1081510

2,138 views
1 citation

Case Report

Published on 09 Jan 2023

Undifferentiated hepatic carcinoma with osteoclast-like giant cells: A case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yujiao Deng
Ya Wang
Yan Zhang
Na Yang
Xingli Ji
Bing Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1018617

1,683 views
1 citation

Original Research

Published on 06 Jan 2023

Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ren-Qian Huang
You Zhou
Hai-Xia Zheng
Dan Wang
Xiao-Yi Zheng
Zhao-Shen Li
Liang-Hao Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.1026268

1,375 views

Mini Review

Published on 06 Jan 2023

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Christabelle Rajesh
Prakash Radhakrishnan

Frontiers in Oncology

doi 10.3389/fonc.2022.1093496

4,129 views
8 citations

Original Research

Published on 04 Jan 2023

Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Mei Li
Kai Zhang
Ji’an He
Weihao Zhang
Tianye Lv
Li Wang
Wenge Xing
Haipeng Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.1071860

2,898 views
2 citations

Original Research

Published on 04 Jan 2023

Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Gang Hou
Bo Liu
Zhong-Qi Fan
Chao Li
Jian-Ping Zhang
Yan-Hui Guo
Ru-Yi Zhang
Yi Zheng
Hong Zhu
Nan-Ya Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1094104

1,245 views
1 citation

Navigation group

Articles

Non-enhanced magnetic resonance imaging-based radiomics model for the differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma

Age independent survival benefit for patients with small hepatocellular carcinoma undergoing percutaneous cryoablation: A propensity scores matching study

Developing and validating a nomogram based on skeletal muscle index and clinical scoring system for prediction of liver failure after hepatectomy

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis

Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation

Long-term effect of anesthesia choice on patients with hepatocellular carcinoma undergoing open liver resection

A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma

Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response

The evolving role of radiation in pancreatic cancer

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression

Undifferentiated hepatic carcinoma with osteoclast-like giant cells: A case report and literature review

Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers

Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis

Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China